Diabetes Research

Novel therapeutic targets available for diabetes includes Incretion based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management control have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.

  • Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes
  • Diabetes and cancer
  • Oral therapies: secretagogues
  • Incretin based therapies
  • Novel agents in treatment
  • Updates of anti-diabetic agents
  • Measurement of insulin resistance and secretion in diabetes clinic
  • Diabetes Case Reports

Related Conference of Diabetes Research

June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
July 20-21, 2026

6th World Congress on Endocrine and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
August 20-21, 2026

6th Annual Summit on Diabetes and Endocrinology

Paris, France
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France
October 20-21, 2026

32nd World Diabetes & Heart Congress

Amsterdam, Netherlands
March 29-30, 2027

8th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Diabetes Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in